|
Real-time Estimate
Cboe Europe
09:44:57 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2,014.50 DKK | -1.10% |
|
+8.31% | +0.30% |
| 08-12 | BNP Paribas Initiates Genmab at Outperform, With $40 Price Target | MT |
| 08-12 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
| Market Cap | 122B 18.77B 16.26B 15.24B 13.9B 26.13B 1,790B 26.53B 179B 70.06B 896B 70.48B 68.95B 2,989B | P/E 2026 * |
25.7x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 141B 21.8B 18.89B 17.7B 16.14B 30.35B 2,079B 30.81B 208B 81.36B 1,041B 81.85B 80.07B 3,472B | EV / Sales 2026 * |
4.87x | EV / Sales 2027 * | 3.94x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab A/S
| 1 day | -0.54% | ||
| 1 week | +7.99% | ||
| Current month | +9.07% | ||
| 1 month | +6.49% | ||
| 3 months | +20.37% | ||
| 6 months | +6.43% |
| 1 week | 1,958.5 |  | 2,066 |
| 1 month | 1,819.5 | | 2,066 |
| Current year | 1,512 | | 2,257 |
| 1 year | 1,440.5 | | 2,257 |
| 3 years | 1,157 | | 2,710 |
| 5 years | 1,157 | | 3,327 |
| 10 years | 786.2 | | 3,327 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2010-05-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 2020-02-29 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 2003-10-31 | |
| Director/Board Member | 58 | 2014-12-31 | |
| Director/Board Member | 75 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/1/25 | Fiscal year | Director | 189 | 0.0003% | ||
| 12/1/25 | Fiscal year | Director | 283 | 0.0004% | ||
| 12/1/25 | Fiscal year | Director | 189 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +7.99% | +41.01% | -20.04% | 18.77B | |
| -0.73% | +7.82% | +73.81% | +102.34% | 70.1B | |
| -0.39% | +0.56% | +37.62% | +65.83% | 54.93B | |
| -0.22% | +33.59% | +8.43% | +489.75% | 28.89B | |
| +0.04% | +10.49% | +48.44% | +7.45% | 23.9B | |
| -0.06% | +0.61% | -16.45% | -13.26% | 23.3B | |
| -1.37% | +7.87% | +251.71% | +464.53% | 18.41B | |
| -0.57% | +3.44% | +25.60% | +619.86% | 16.1B | |
| -1.85% | -11.15% | +32.75% | +134.11% | 12.48B | |
| -2.23% | +0.39% | +390.17% | +202.43% | 12.32B | |
| Average | -0.79% | +7.58% | +89.31% | +205.30% | 27.92B | |
| Weighted average by Cap. | -0.63% | +9.03% | +69.10% | +168.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29.01B 4.48B 3.88B 3.64B 3.32B 6.23B 427B 6.33B 42.75B 16.71B 214B 16.81B 16.45B 713B | 33.71B 5.2B 4.51B 4.22B 3.85B 7.24B 496B 7.35B 49.68B 19.42B 248B 19.54B 19.11B 829B |
| Net income | 4.94B 763M 661M 619M 565M 1.06B 72.74B 1.08B 7.28B 2.85B 36.42B 2.86B 2.8B 121B | 7.17B 1.11B 959M 899M 820M 1.54B 106B 1.56B 10.57B 4.13B 52.88B 4.16B 4.07B 176B |
| Net Debt | 19.62B 3.03B 2.62B 2.46B 2.24B 4.22B 289B 4.28B 28.92B 11.3B 145B 11.37B 11.12B 482B | 11.13B 1.72B 1.49B 1.39B 1.27B 2.39B 164B 2.43B 16.4B 6.41B 82.04B 6.45B 6.31B 274B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | DKK 2,038.00 | +0.05% | 24,065 |
| 26-08-12 | DKK 2,037.00 | +2.21% | 133,012 |
| 26-08-11 | DKK 1,993.00 | +0.05% | 87,351 |
| 26-08-10 | DKK 1,992.00 | -0.35% | 129,558 |
| 26-08-07 | DKK 1,999.00 | +6.50% | 316,139 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
